Search results
CNBC's Inside India newsletter: Modi's loss could be India's gain
CNBC· 3 days agoThis report is from this week's CNBC's "Inside India" newsletter which brings you timely, insightful...
Why the 'bad news is good news' trend didn't work with Monday's economic data
CNBC· 6 days agoEvery weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable...
Real estate billionaire Barry Sternlicht says rents will rise in two years—and it’s Jerome Powell’s...
Fortune via AOL· 3 days agoBut the boom is over, and now property owners are struggling to fill vacancies, which is causing...
Cruises tend to be cheaper than hotel vacations, and that's good news for these stocks
CNBC· 1 day agoCruise operators have been enjoying strong demand since climbing out of the Covid pandemic, which...
'Much higher than expected': U.S. job market adds 272,000 positions in May
MSNBC· 2 days agoThe U.S. economy added 272,000 jobs in May, bringing good news for workers but potentially...
The Paramount Merger Seems To Be Happening. Why I Think This Is Best Case Scenario For Both Parties
CinemaBlend via Yahoo Finance· 6 days agoFor anyone who has a Paramount+ subscription, but doesn’t want to open a Prime Video account just to...
Forcing people back into the office is once again leading to increased carbon emissions
Stacker via AOL· 4 days agoLife was often lonely for those stuck in their homes, but people found something to appreciate when...
Nvidia Reaches $3 Trillion Market Value. It’s the Latest Sign of Chip Demand.
Barrons.com· 4 days agoNvidia shares hit a historic milestone Wednesday afternoon, closing above $3 trillion in market...
Young job seekers are finding it tougher to find employment, despite a bustling labor market: 'It...
CNBC· 3 days agoSamantha McCloud, 16, left, Victoria Garcia, 16, Jessel Rincon, 16, at college and career fair at...
JD Supra: Better Health Care Newsletter
JD Supra· 3 days agoFederal officials have capped the cost of insulin at $35 a month. For now, that gives relief only to patients 65 and older covered by Medicare. Big Pharma in recent years has flouted that charitable intent.